Trial Profile

Phase III study of udenafil in Fontan subjects

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 23 Feb 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Udenafil (Primary)
Indications Congenital heart defects; Ventricular dysfunction
Focus Therapeutic Use
Acronyms FUEL-2 Trial
Sponsors Mezzion

Most Recent Events

23 Feb 2023 New trial record
21 Feb 2023 According to Mezzion media release, the study enrollment is expected to be imitated within the next few weeks.
21 Feb 2023 According to Mezzion media release, approximately 30 study sites are planned throughout the world.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com